PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Beijing Center for Disease Prevention and Control, Beijing, China.\', \'Beijing Research Center for Preventive Medicine, Beijing, China.\', \'School of Public Health, Capital Medical University, Beijing, China.\', \'Beijing YouAn Hospital, Capital Medical University, Beijing, China.\', \'Sinovac Biotech Co, Ltd, Beijing, China.\', \'Xicheng District Center for Disease Prevention and Control, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa721
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32497196
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32497196>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32497196>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all